JPS62298761A - Fluorescent immunoassay - Google Patents
Fluorescent immunoassayInfo
- Publication number
- JPS62298761A JPS62298761A JP14130786A JP14130786A JPS62298761A JP S62298761 A JPS62298761 A JP S62298761A JP 14130786 A JP14130786 A JP 14130786A JP 14130786 A JP14130786 A JP 14130786A JP S62298761 A JPS62298761 A JP S62298761A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- bonding
- labelled
- antibodies
- beads
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003018 immunoassay Methods 0.000 title claims description 7
- 108060006184 phycobiliprotein Proteins 0.000 claims abstract description 15
- 239000000427 antigen Substances 0.000 claims abstract description 12
- 102000036639 antigens Human genes 0.000 claims abstract description 12
- 108091007433 antigens Proteins 0.000 claims abstract description 12
- 239000011324 bead Substances 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 abstract description 7
- 230000005284 excitation Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 102000009027 Albumins Human genes 0.000 abstract description 3
- 108010088751 Albumins Proteins 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 229940098197 human immunoglobulin g Drugs 0.000 abstract description 3
- 229920002401 polyacrylamide Polymers 0.000 abstract description 3
- 239000006228 supernatant Substances 0.000 abstract description 3
- 239000000872 buffer Substances 0.000 abstract description 2
- 229940099472 immunoglobulin a Drugs 0.000 abstract description 2
- 239000000725 suspension Substances 0.000 abstract description 2
- 238000005406 washing Methods 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract 2
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 7
- 108010053210 Phycocyanin Proteins 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 108010004469 allophycocyanin Proteins 0.000 description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 description 4
- 108010004729 Phycoerythrin Proteins 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 238000006862 quantum yield reaction Methods 0.000 description 3
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- -1 R-phycocyanin Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- CORXEUSRKLNMDW-UHFFFAOYSA-N 3-[[1-(2,5-dioxopyrrolidin-1-yl)-2h-pyridin-2-yl]disulfanyl]propanoic acid Chemical compound OC(=O)CCSSC1C=CC=CN1N1C(=O)CCC1=O CORXEUSRKLNMDW-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 1
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229940096329 human immunoglobulin a Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
【発明の詳細な説明】
3、発明の詳細な説明
〔産業上の利用分野〕
本発明はイムノアッセイ法に係り、特に生体試料中の微
量成分の検出に好適なイムノアッセイ法に関する。Detailed Description of the Invention 3. Detailed Description of the Invention [Field of Industrial Application] The present invention relates to an immunoassay method, and particularly to an immunoassay method suitable for detecting trace components in biological samples.
従来、フィコビリ蛋白質を用いたイムノアッセイ法とし
ては、クリニカル・ケミストリー、第29巻(1983
年)第1582頁から第1586頁(CIin、 Ch
ew、、 29 、 (1983)Pρ、1582−
1586)においてフィコエリトリンを用いたイムノア
ッセイ法が論じられているが、一種類の蛋白質を用いた
ものであり、複数種のフィコビリ蛋白質を異なる抗体に
結合させてアッセイに用いた例は知られていない。Conventionally, immunoassay methods using phycobiliproteins have been described in Clinical Chemistry, Vol. 29 (1983).
) pages 1582 to 1586 (CIin, Ch.
ew,, 29, (1983) Pρ, 1582-
1586) discusses an immunoassay method using phycoerythrin, but it uses one type of protein, and there is no known example of using multiple types of phycobiliproteins in an assay by binding them to different antibodies.
上記従来技術は一種類のフィコビリ蛋白質の利用につい
て論じており、複数の測定対象を同一の試料から検出す
るという点については配慮がされていないため、ある疾
患を、またある生体の状態を総合的に判断するのに十分
な情報が迅速に得られなかった。また低分子の有機蛍光
物質を種類を変えて標識する方法も考えられるが、これ
らの標識試薬は一般に、水への溶解性が低く、抗体への
結合が容易でなく、量子収率やモル吸光係数もごく一部
の試薬(フルオレセインやローダミンB)を除けば小さ
いなどの問題のために、複数の抗原を感度良く同時に測
定するのはきわめて難しかった。The above-mentioned conventional technology discusses the use of one type of phycobiliprotein and does not take into consideration the detection of multiple measurement targets from the same sample. Not enough information could be obtained quickly to make a decision. Another option is to label different types of low-molecular organic fluorescent substances, but these labeling reagents generally have low solubility in water, are difficult to bind to antibodies, and have low quantum yield and molar absorption. Due to problems such as low coefficients except for a few reagents (fluorescein and rhodamine B), it has been extremely difficult to measure multiple antigens simultaneously with high sensitivity.
本発明の目的は、複数の抗原を含む同一の試料から抗原
を高感度に測定することにある。An object of the present invention is to measure antigens with high sensitivity from the same sample containing multiple antigens.
上記目的を達成するために、蛍光性色素蛋白質であるC
−フィコエリトリン、B−フィコエリトリン、R−フィ
コエリトリン、C−フィコシアニン、R−フィコシアニ
ン、アロフィコシアニンなどから成るフィコビリ蛋白質
を用い、抗体と結合させ、イムノアッセイに適用した。In order to achieve the above purpose, C
- Phycobili proteins consisting of phycoerythrin, B-phycoerythrin, R-phycoerythrin, C-phycocyanin, R-phycocyanin, allophycocyanin, etc. were used, combined with antibodies, and applied to immunoassays.
ここで抗体とは抗体のFab’成分(活性を有する切断
断片)も含むものとする。抗体とフィコビリ蛋白質の結
合は常法([蛋白質の化学修飾(」二、下)」。Here, the term "antibody" includes the Fab' component (active cleavage fragment) of the antibody. Binding of antibodies and phycobiliproteins is carried out by a conventional method ([Chemical modification of proteins (2, 2)].
大野、金岡、崎山、前田著、学会出版センター刊198
1年など)に従って、抗体のアミノ基、またはカルボキ
シル基とフィコビリ蛋白質のカルボキシル基またはアミ
ノ基とを架橋試薬で結合させるか、又は抗体のFab’
成分のチオール基とフィコビリ蛋白質のアミノ基とを同
様な方法で結合させる方法で行なうことができる。Written by Ohno, Kanaoka, Sakiyama, and Maeda, published by Gakkai Publishing Center, 198.
1 year, etc.), the amino group or carboxyl group of the antibody and the carboxyl group or amino group of the phycobiliprotein are bonded with a cross-linking reagent, or the Fab' of the antibody is
This can be carried out by bonding the thiol group of the component and the amino group of the phycobiliprotein in a similar manner.
フィコビリ蛋白質は一群の蛍光性色素蛋白質であり、吸
光波長、蛍光波長とも480nm以上と共存成分の妨害
を受けにくい長波長領域にある。Phycobiliproteins are a group of fluorescent pigment proteins, and both absorption and fluorescence wavelengths are in the long wavelength region of 480 nm or more, which is less susceptible to interference by coexisting components.
また量子収率も0.51−0.98ときわめて高く、−
T−/L/吸光係数も2.3−24.IX]05M
”cm ’と非常に大きい。低分子蛍光物質フルオレ
セイン(モル吸光係数9 X 10 ’ M ’ c
m ’ 。In addition, the quantum yield is extremely high at 0.51-0.98, -
T-/L/extinction coefficient is also 2.3-24. IX]05M
Very large at ``cm''.Low molecular fluorescent substance fluorescein (molar extinction coefficient 9 x 10'M'c
m'.
量子収率0.65)の数倍から数十倍の蛍光強度が得ら
れる。主なフィコビリ蛋白質としてはB−とb−とR−
フィコエリトリン、C−とR−フィコシアニン、アロフ
ィコシアニンがある。蛋白質なので水溶性であり、抗体
と結合させるための官能基も容易に利用できる。A fluorescence intensity several to several tens of times higher than the quantum yield (0.65) can be obtained. The main phycobiliproteins are B-, b-, and R-
These include phycoerythrin, C- and R-phycocyanin, and allophycocyanin. Since it is a protein, it is water-soluble, and functional groups for binding to antibodies are easily available.
以下、本発明の実施例を述べる。 Examples of the present invention will be described below.
実施例I
R−フィコエリトリンと抗ヒトアルブミン抗体とに、と
もにN−スクシンイミジル−3−(2−ピリジルジチオ
)プロピオン酸でチオール基を導入する(クリニカル・
ケミストリー(CHn。Example I A thiol group is introduced into R-phycoerythrin and an anti-human albumin antibody using N-succinimidyl-3-(2-pyridyldithio)propionic acid (clinical method).
Chemistry (CHn.
Chem、)29.1582 (1983)参照)。チ
オール化した抗体とR−フィコエリトリンを混合し、S
H,−8−8−交換反応により両者を結合させる。過剰
のチオール基はN−エチルマレイミドで不活性にする。Chem, ) 29.1582 (1983)). Mix thiolated antibody and R-phycoerythrin,
Both are combined by H, -8-8- exchange reaction. Excess thiol groups are rendered inactive with N-ethylmaleimide.
一方、C−フィコシアニンと抗ヒト免疫グロブリンG抗
体とに同様にしてチオール基を導入し、上記のようにC
−フィコシアニン標識抗体を調製する。さらにアロフィ
コシアニンを抗ヒト免疫グロブリンAに同様にして結合
させる。On the other hand, thiol groups were introduced into C-phycocyanin and anti-human immunoglobulin G antibody in the same manner, and C-phycocyanin and anti-human immunoglobulin G antibodies were introduced in the same manner.
- Prepare phycocyanin-labeled antibodies. Furthermore, allophycocyanin is bound to anti-human immunoglobulin A in the same manner.
以上3種のフィコビリ蛋白質標識抗体を使用して、ヒト
血清中のアルブミン、免疫グロブリンG。Albumin and immunoglobulin G in human serum were detected using the above three types of phycobiliprotein-labeled antibodies.
免疫グロブリンAを測定した。まず3種の混合標準溶液
(アル1足25
ブリン0 3 g / 1 0 0 m Q 、免疫グ
ロブリンAO.5g/loomQを含む生理的食塩水)
を希釈しておく。一方標識していない抗体3種類をそれ
ぞれカルボキシル化ポリアクリルアミドゲルのビーズ(
直径3μmから10μm)に固定化しておいた。この3
種のビーズ懸濁液を等量試験管に取り、これに混合標準
溶液を加え、約1時間37℃で反応させ、遠心分離し、
上澄みを捨てた。次に前記3種類の標識抗体液を加え、
約1時間37℃で反応させた。これに洗浄用緩衝液(P
H7.4。Immunoglobulin A was measured. First, three mixed standard solutions (physiological saline containing AO.5g/roomQ, immunoglobulin AO.5g/roomQ)
Dilute it. On the other hand, three types of unlabeled antibodies were each placed on carboxylated polyacrylamide gel beads (
(diameter 3 μm to 10 μm). This 3
Take an equal amount of the seed bead suspension into a test tube, add the mixed standard solution to it, react at 37°C for about 1 hour, centrifuge,
The supernatant was discarded. Next, add the three types of labeled antibody solutions,
The reaction was carried out at 37°C for about 1 hour. Add washing buffer (P
H7.4.
0、01Mリン酸ナトリウム緩衝液、0.15Mの塩化
ナトリウムを含む)を加え、よくかくはんしたのち、遠
心分離し、上澄みを捨てる。沈殿したポリアクリルアミ
ド・ビーズを測定用緩衝液(pH7.4,0.05Mリ
ン酸緩衝液)に懸濁し、直ちに、蛍光測定セルに移し、
蛍光強度を測定した。R−フィコエリトリンは励起波長
480nm。After stirring well, centrifuge and discard the supernatant. The precipitated polyacrylamide beads were suspended in a measurement buffer (pH 7.4, 0.05M phosphate buffer) and immediately transferred to a fluorescence measurement cell.
Fluorescence intensity was measured. R-phycoerythrin has an excitation wavelength of 480 nm.
発光波長580nm,C−フィコシアニンは励起波長6
20nm,発光波長650nm,アロフィコシアニンは
励起波長650nm,発光波長665nmで順次測定し
た。この測定操作による検量線を第1図に示す。各測定
対象ともほぼ良好な検量線が得られた。本検量線を用い
てヒト血清20検体について上記の操作によりアッセイ
を行った結果を、比ろう法(ネフェロメータ)による測
定値を比較したところ、相関係数0.97〜0、98と
良好な一致が見られた。Emission wavelength 580 nm, C-phycocyanin excitation wavelength 6
Allophycocyanin was measured sequentially at an excitation wavelength of 650 nm and an emission wavelength of 665 nm. A calibration curve obtained by this measurement procedure is shown in FIG. Approximately good calibration curves were obtained for each measurement target. The results of assaying 20 human serum samples according to the above procedure using this standard curve were compared with the measured values using a nephelometer, and the correlation coefficient was 0.97 to 0.98, indicating good agreement. It was observed.
実施例2
ポリスチレン試験管に測定対象に対する抗体を固定して
おく。本実施例では抗ヒトα−フェトプロティン抗体と
抗フェリチン抗体とを吸着させておいた。この試験管に
抗原を含む試料を入れ、抗体と約2時間反応させた。次
にいったん試験管を洗浄用緩衝液で洗浄したのち、C−
フィコシアニンで標識した抗ヒトα−フェトプロティン
抗体とR−フィコエリトリンで標識した抗フェリチン抗
体とをO,1mg/mfl程度含有するリン酸緩衝生理
的食塩水(pH7,4)を加え、37℃で約1時間保っ
た。試験管内の溶液を吸引し、蛍光光度計のフローセル
中に導いて蛍光強度を測定し、その強度の減少度合から
抗原濃度を測定した。両抗原を任意に混合した標準試料
20検体で両者を別々に測定できた。Example 2 An antibody against a measurement target is immobilized on a polystyrene test tube. In this example, an anti-human α-fetoprotein antibody and an anti-ferritin antibody were adsorbed. A sample containing the antigen was placed in this test tube and reacted with the antibody for about 2 hours. Next, after washing the test tube with washing buffer,
Phosphate buffered saline (pH 7.4) containing about 1 mg/mfl of anti-human α-fetoprotein antibody labeled with phycocyanin and anti-ferritin antibody labeled with R-phycoerythrin was added, and the mixture was heated at 37°C to approx. I kept it for an hour. The solution in the test tube was aspirated and introduced into a flow cell of a fluorometer to measure the fluorescence intensity, and the antigen concentration was determined from the degree of decrease in the intensity. Both antigens could be measured separately using 20 standard samples in which both antigens were mixed arbitrarily.
本発明は、高感度多項目分析という目的に対して蛍光強
度が強く、異なる励起・発光スペクトルを有する複数の
フィコビリ蛋白質を利用することにより、同一の試料か
ら複数の抗原を感度良く測定できる。The present invention makes it possible to measure multiple antigens from the same sample with high sensitivity by utilizing multiple phycobiliproteins with strong fluorescence intensity and different excitation and emission spectra for the purpose of highly sensitive multi-item analysis.
また同一の試料で複数の抗原を測定できることから総測
定時間の短縮、試料量の減少という効果が得られる。Furthermore, since multiple antigens can be measured in the same sample, the total measurement time can be shortened and the amount of sample can be reduced.
第1図は本発明の実施例1で使用した検量線を示す図で
ある。FIG. 1 is a diagram showing a calibration curve used in Example 1 of the present invention.
Claims (1)
た抗体を被測定抗原ごとに調製する工程と、上記抗体を
複数の被測定抗原を含む試料と反応させる工程とよりな
ることを特徴とする蛍光イムノアッセイ法。1. A fluorescence immunoassay characterized by comprising the steps of preparing an antibody bound to phycobiliproteins having different fluorescence emission wavelengths for each antigen to be measured, and reacting the antibody with a sample containing a plurality of antigens to be measured. Law.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14130786A JPS62298761A (en) | 1986-06-19 | 1986-06-19 | Fluorescent immunoassay |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14130786A JPS62298761A (en) | 1986-06-19 | 1986-06-19 | Fluorescent immunoassay |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62298761A true JPS62298761A (en) | 1987-12-25 |
Family
ID=15288846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14130786A Pending JPS62298761A (en) | 1986-06-19 | 1986-06-19 | Fluorescent immunoassay |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62298761A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58140641A (en) * | 1982-02-17 | 1983-08-20 | Hitachi Ltd | Quantitative determination method of immunity |
JPS58160866A (en) * | 1981-10-06 | 1983-09-24 | ザ・ボ−ド・オブ・トラステイ−ズ・オブ・ザ・リ−ランド・スタンフオ−ド・ジユニア・ユニバ−シテイ | Fluorescent compound |
-
1986
- 1986-06-19 JP JP14130786A patent/JPS62298761A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58160866A (en) * | 1981-10-06 | 1983-09-24 | ザ・ボ−ド・オブ・トラステイ−ズ・オブ・ザ・リ−ランド・スタンフオ−ド・ジユニア・ユニバ−シテイ | Fluorescent compound |
JPS58140641A (en) * | 1982-02-17 | 1983-08-20 | Hitachi Ltd | Quantitative determination method of immunity |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4133639A (en) | Test article including a covalently attached diagnostic reagent and method | |
KR100804202B1 (en) | Chromatographic assay system | |
US6376187B1 (en) | Electronically-indexed solid-phase assay for biomolecules | |
JP2002303629A (en) | Immune chromatography device and method for determining substance to be tested using the same | |
JPH03502244A (en) | Test method and reagent kit | |
US6551788B1 (en) | Particle-based ligand assay with extended dynamic range | |
JP2008304401A (en) | Label silica nano-particle for immuno-chromatography reagent, immuno-chromatography reagent, test strip for immuno-chromatography using it, and fluorescence detecting system for immuno-chromatography | |
JP2007519933A (en) | Systems, methods, and reagents for detection of biological and chemical materials using dynamic surface generation and imaging | |
JP2009115822A (en) | Label silica nano-particle for immuno-chromatography reagent, immuno-chromatography reagent, test strip for immuno-chromatography using it, and fluorescence detection system for immuno-chromatography | |
CN113156119A (en) | Method for detecting coronavirus by adopting angiotensin converting enzyme II (ACE2) | |
WO2017206800A1 (en) | Centrifugal chromatography immunoassay method | |
CN111381025A (en) | Immunoassay kit for multiplex detection, application and multiplex detection method | |
JP5006459B1 (en) | Composite particles for labeling | |
US20200333337A1 (en) | Method for re-using test probe and reagents in an immunoassay | |
US20210164974A1 (en) | Chromatographic strip comprising multiple test lines, diagnostic kit comprising same, and qualitative, semi-quantitative or quantitative analysis method comprising multiple competitive reaction measurement steps | |
WO2019088142A1 (en) | Detection agent for bioassay and signal amplification method using same | |
US20230305001A1 (en) | Ultra-sensitive digital rapid chromatographic assay system and method for analytes detection | |
US20160341723A1 (en) | Au nanoparticles encapsulated in nanocompoites and applications thereof in rapid detection of an analyte | |
KR101548284B1 (en) | A Novel Method for Detecting an Analyte and Kits Using It | |
EP0201211A1 (en) | Method and compositions for visual solid phase immunoassays based on luminescent microspheric particles | |
CN100414296C (en) | Embedded high-pass three-dimensional biological detecting technique and agent box | |
JPH03272466A (en) | Multiple immunologocal evaluating analyzing system | |
JPS62298761A (en) | Fluorescent immunoassay | |
JPS6281566A (en) | Quantification method by measurement of fluorescent intensity of fine particle | |
CN112782404B (en) | Multiplex biomarker detection kit based on fluorescence immunoassay method |